FDA Inspection
James A. Tumlin, MDJames A. Tumlin, MD – FDA Inspection, Sep 4, 2025
Record Details
This FDA Inspection record concerns James A. Tumlin, MD, with an inspection on September 4, 2025, issued by the Atlanta District Office, covering human drugs.
- Office
- Atlanta District Office
- Person
View Company Profile
ID · fa3d22c6-6281-4529-be3b-0e0a7077ba07
Inspection Facts
- Inspection number
- 1281017
- FDA center
- Human Drugs
Other FDA inspections of James A. Tumlin, MD
4| Date | Classification | Office | Project area |
|---|---|---|---|
| September 16, 2020 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 2, 2020 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 22, 2017 | NAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
| August 2, 2013 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for James A. Tumlin, MD
- FDA Inspection 1130277 - 2020-09-16
- FDA Inspection 1129929 - 2020-09-02
- FDA Inspection 1030243 - 2017-09-22
- FDA Inspection 844023 - 2013-08-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.